Azithromycin treatment alters gene expression in inflammatory, lipid metabolism, and cell cycle pathways in well-differentiated human airway epithelia.
about
Azithromycin may antagonize inhaled tobramycin when targeting Pseudomonas aeruginosa in cystic fibrosisThe ER stress transducer IRE1β is required for airway epithelial mucin productionA platform for processing expression of short time series (PESTS).Cystic fibrosis remodels the regulation of purinergic signaling by NTPDase1 (CD39) and NTPDase3Antimycobacterial drugs modulate immunopathogenic matrix metalloproteinases in a cellular model of pulmonary tuberculosis.The combined effect of azithromycin and insulin-like growth factor-1 on cultured human meibomian gland epithelial cells.SPLUNC1 expression reduces surface levels of the epithelial sodium channel (ENaC) in Xenopus laevis oocytes.Suppressive effects of azithromycin on zymosan-induced production of proinflammatory mediators by human corneal epithelial cellsHyperoxia impairs alveolar formation and induces senescence through decreased histone deacetylase activity and up-regulation of p21 in neonatal mouse lung.Toll-like receptor 2 mediates fatal immunopathology in mice during treatment of secondary pneumococcal pneumonia following influenzaPotential of anti-inflammatory treatment for cystic fibrosis lung disease.Baseline Goblet Cell Mucin Secretion in the Airways Exceeds Stimulated Secretion over Extended Time Periods, and Is Sensitive to Shear Stress and Intracellular Mucin Stores.Pathogen- and host-directed anti-inflammatory activities of macrolide antibioticsOmics approaches in cystic fibrosis research: a focus on oxylipin profiling in airway secretions.CFTR, mucins, and mucus obstruction in cystic fibrosis.X-Box-Binding Protein 1 and Innate Immune Responses of Human Cystic Fibrosis Alveolar Macrophages.A European perspective on topical ophthalmic antibiotics: current and evolving options.Diffuse parenchymal lung disease caused by surfactant deficiency: dramatic improvement by azithromycin.Effects of azithromycin in Pseudomonas aeruginosa burn wound infection.The differential effects of azithromycin on the airway epithelium in vitro and in vivo.Inflammation promotes airway epithelial ATP release via calcium-dependent vesicular pathways.Role of endoplasmic reticulum stress in cystic fibrosis-related airway inflammatory responsesChallenges and advances in the development of inhalable drug formulations for cystic fibrosis lung disease.Bronchial brushings for investigating airway inflammation and remodelling.Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases.Antibacterial and immunomodulatory properties of azithromycin treatment implications for periodontitis.Azithromycin improves lung function in patients with post-lung transplant bronchiolitis obliterans syndrome: a meta-analysis.Inflammation and its genesis in cystic fibrosis.Activation of MMP-9 by human lung epithelial cells in response to the cystic fibrosis-associated pathogen Burkholderia cenocepacia reduced wound healing in vitro.One man's poison is another man's meat: using azithromycin-induced phospholipidosis to promote ocular surface health.From the Cover: Exposure to Oral Antibiotics Induces Gut Microbiota Dysbiosis Associated with Lipid Metabolism Dysfunction and Low-Grade Inflammation in Mice.Effect of brimonidine, an α2 adrenergic agonist, on human meibomian gland epithelial cells.
P2860
Q33640512-52175C3B-B9ED-443B-9B6C-FAC92A1E5757Q33652759-B5A00217-6DF7-4590-993A-EE7434C4FCEDQ33790481-AE9D59B8-534B-4EBE-91A4-B3A5A4028FC6Q33916983-25A02E6E-6F77-4CAB-92B0-4605049077D0Q34058316-D9562B13-2CBD-4D76-8610-B0AFFF3307A9Q34159564-B6B3BEA0-3084-4D50-8105-2AB944B04C67Q34288462-08A1EFA3-7FA3-47AF-B507-CD60FD16A951Q34702025-C5932C3A-375A-45ED-AD49-1AAC7B9826ABQ34974289-E4B11847-96A0-4EF5-8249-2E65EA52012BQ35557119-FB5D0F89-761B-4DBC-82A9-C63C6F80E855Q35557381-8ED03256-D23B-42A7-A822-0472BD251626Q35646365-DFECB773-A70F-469C-88F7-B2366F2B122DQ36072425-5F519097-6D82-46E6-A48D-648E29EC33D8Q36112019-9F4AF402-2954-4D01-9FD1-C5E7F0C509CEQ36186528-DB0C4E2F-1934-4651-A4C7-6C09666FC043Q36516884-96ACA4D7-4ABE-4E92-AE98-568BAB2852DDQ36867161-8E9EC884-C677-4A63-BAD0-B8C2C6DACED0Q36987036-490E9008-03CF-40E2-A5C2-AD3C68B9CA89Q37018035-FFC55DA7-F7D3-4CEE-92F1-2477A7D93E7CQ37286810-8303499F-232B-4ADB-B884-DDDDC1D033D8Q37596443-E09A4857-0B2F-498F-BDC6-A41A4CD190F5Q37804627-8DC81BDE-0EEE-469E-964B-FC2E15A88D33Q37849777-E733B4F3-79DB-416E-BFC4-F54084588B4EQ37882032-B5B20F31-823E-44E7-A1EA-28DF1B1ED822Q37959271-8414B9C9-37FF-4968-AE7C-B2C0CDBAC0D7Q38085248-9060726A-368E-4944-A715-5CC4206E802BQ38220399-FBBDB06D-9DCA-46D5-A807-DB68CAEA306DQ38579962-70E3F072-7277-4119-AA46-AF86C15DF418Q39509508-3A975EDB-E2EE-4962-B747-EB238262D2A2Q39738019-71FB3728-17C5-4BD4-9EDE-EC2F48F4A905Q42694363-F76AD258-627F-445B-B453-F2C38103EEFBQ49923423-D340A82B-ED69-4393-83A0-49F3E1002C21
P2860
Azithromycin treatment alters gene expression in inflammatory, lipid metabolism, and cell cycle pathways in well-differentiated human airway epithelia.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Azithromycin treatment alters ...... tiated human airway epithelia.
@ast
Azithromycin treatment alters ...... tiated human airway epithelia.
@en
type
label
Azithromycin treatment alters ...... tiated human airway epithelia.
@ast
Azithromycin treatment alters ...... tiated human airway epithelia.
@en
prefLabel
Azithromycin treatment alters ...... tiated human airway epithelia.
@ast
Azithromycin treatment alters ...... tiated human airway epithelia.
@en
P2093
P2860
P1433
P1476
Azithromycin treatment alters ...... tiated human airway epithelia.
@en
P2093
Brian Brighton
Carla Maria P Ribeiro
Harry Hurd
Lisa Jones
Mary E B Martino
Richard C Boucher
Wanda K O'Neal
P2860
P356
10.1371/JOURNAL.PONE.0005806
P407
P577
2009-06-05T00:00:00Z